Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Utilization | 2 | 2021 | 1237 | 0.550 |
Why?
|
| Antibodies | 1 | 2021 | 2426 | 0.460 |
Why?
|
| Biological Products | 1 | 2021 | 839 | 0.430 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1788 | 0.400 |
Why?
|
| International Classification of Diseases | 3 | 2022 | 855 | 0.300 |
Why?
|
| Keratolytic Agents | 1 | 2005 | 29 | 0.290 |
Why?
|
| Teratogens | 1 | 2005 | 116 | 0.270 |
Why?
|
| Isotretinoin | 1 | 2005 | 107 | 0.260 |
Why?
|
| Healthcare Common Procedure Coding System | 1 | 2019 | 1 | 0.200 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 297 | 0.180 |
Why?
|
| Arthroplasty, Replacement | 1 | 2022 | 324 | 0.170 |
Why?
|
| Insurance Claim Review | 2 | 2022 | 749 | 0.170 |
Why?
|
| Diagnosis-Related Groups | 1 | 2019 | 454 | 0.160 |
Why?
|
| Lyme Disease | 1 | 2022 | 605 | 0.150 |
Why?
|
| Metformin | 1 | 2022 | 805 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 1686 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2022 | 961 | 0.140 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 498 | 0.130 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 689 | 0.120 |
Why?
|
| Caregivers | 4 | 2004 | 1925 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 3843 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4449 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2021 | 2495 | 0.080 |
Why?
|
| United States | 10 | 2022 | 67895 | 0.080 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 474 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2022 | 7901 | 0.060 |
Why?
|
| United States Food and Drug Administration | 2 | 2022 | 1777 | 0.060 |
Why?
|
| Algorithms | 1 | 2022 | 13761 | 0.050 |
Why?
|
| Risk Management | 1 | 2005 | 572 | 0.050 |
Why?
|
| Home Care Services | 2 | 2004 | 594 | 0.050 |
Why?
|
| Long QT Syndrome | 1 | 2005 | 421 | 0.050 |
Why?
|
| Bereavement | 1 | 2003 | 256 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2023 | 635 | 0.050 |
Why?
|
| Clinical Coding | 1 | 2021 | 176 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11098 | 0.040 |
Why?
|
| Drugs, Generic | 1 | 2005 | 520 | 0.040 |
Why?
|
| Adolescent | 4 | 2021 | 85064 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2005 | 1586 | 0.040 |
Why?
|
| Adult | 7 | 2022 | 212237 | 0.040 |
Why?
|
| Aged | 9 | 2022 | 162392 | 0.040 |
Why?
|
| Arousal | 1 | 2003 | 1140 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2007 | 7494 | 0.040 |
Why?
|
| Humans | 17 | 2023 | 715594 | 0.040 |
Why?
|
| Health Resources | 1 | 2003 | 929 | 0.040 |
Why?
|
| Middle Aged | 7 | 2021 | 214639 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56140 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 20515 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1042 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2005 | 2652 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2004 | 7259 | 0.030 |
Why?
|
| Male | 9 | 2022 | 350143 | 0.030 |
Why?
|
| Incidence | 2 | 2022 | 20761 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1841 | 0.030 |
Why?
|
| Female | 9 | 2022 | 377052 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2277 | 0.030 |
Why?
|
| Terminal Care | 1 | 2003 | 1638 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2003 | 1618 | 0.030 |
Why?
|
| Age Factors | 2 | 2005 | 18772 | 0.030 |
Why?
|
| Dementia | 1 | 2003 | 2259 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 72448 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 2777 | 0.020 |
Why?
|
| Infant | 3 | 2007 | 34561 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2007 | 41184 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2003 | 4165 | 0.020 |
Why?
|
| Insulin | 1 | 2022 | 6654 | 0.020 |
Why?
|
| Research Design | 2 | 2019 | 5914 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3407 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 2004 | 2313 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 4884 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 14877 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 2005 | 201 | 0.020 |
Why?
|
| Child | 3 | 2007 | 74413 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2005 | 384 | 0.010 |
Why?
|
| Self-Help Groups | 1 | 2003 | 210 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11238 | 0.010 |
Why?
|
| Attitude to Death | 1 | 2003 | 377 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 12490 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2007 | 1439 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 614 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 40040 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2007 | 2538 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1670 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1289 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 19529 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 4903 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2004 | 1999 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2003 | 1571 | 0.010 |
Why?
|
| Depression | 2 | 2003 | 7266 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2005 | 2766 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 3902 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14887 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 6387 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10660 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13605 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 58293 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 8270 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11407 | 0.000 |
Why?
|
| Risk Factors | 1 | 2005 | 70931 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 62039 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_